Related Experiment Video

Updated: Sep 12, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis

J R Govan1, G S Harris

  • 1Department of Bacteriology, University of Edinburgh Medical School, UK.

Microbiological Sciences
|October 1, 1986
PubMed

Insights

Pseudomonas aeruginosa causes opportunistic infections in vulnerable individuals. In cystic fibrosis patients, its chronic lung infection leads to significant illness and death, showcasing microbial adaptation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Host-Pathogen Interactions

Background:

  • Pseudomonas aeruginosa is a versatile bacterium capable of causing opportunistic infections.
  • Chronic pulmonary colonization by mucoid P. aeruginosa is a critical factor in cystic fibrosis morbidity and mortality.
  • This colonization represents a key example of microbial adaptation and host-bacterium dynamics.

Purpose of the Study:

  • To explore the role of Pseudomonas aeruginosa in opportunistic infections.
  • To understand the mechanisms of microbial adaptation in chronic cystic fibrosis lung infections.
  • To investigate the complex interactions between P. aeruginosa and its host in cystic fibrosis.

Main Methods:

  • Literature review on Pseudomonas aeruginosa pathogenesis.
  • Analysis of studies on cystic fibrosis patient cohorts.
  • Examination of microbial adaptation strategies.

Main Results:

  • Pseudomonas aeruginosa demonstrates significant adaptability, leading to opportunistic infections.
  • Mucoid strains of P. aeruginosa are strongly associated with poor outcomes in cystic fibrosis.
  • The interaction highlights bacterial adaptation and host response.

Conclusions:

  • Pseudomonas aeruginosa poses a significant threat to immunocompromised individuals.
  • Effective management of chronic P. aeruginosa infections is crucial for improving cystic fibrosis patient survival.
  • Further research into host-pathogen interactions can reveal therapeutic targets.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 18, 2014

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...